TrialAnnals of surgical oncology2023

A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).

Shin Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.